Molecular Signatures of Esophageal Atresia

计划入组 6 人 · 首次发布于 2023 年 10 月 10 日

Flourish™ Pediatric Esophageal Atresia

计划入组 21 人 · 首次发布于 2018 年 8 月 3 日

Individualized Management for Long Gap Esophageal Atresia

计划入组 30 人 · 首次发布于 2017 年 1 月 18 日

Cellspan Esophageal Implant

LGR5 modulators (esophageal adenocarcinoma)

Neo-antigen DC vaccine (sc, esophageal cancer/carcinoma)

Lucid Diagnostics

United States

PAVmed

United States

Atreca, Inc.

United States

Harvard Apparatus Regenerative Technology Partners with Capital Institute of Pediatrics for Esophageal Atresia Treatment

Harvard Apparatus Regenerative Technology and Capital Institute of Pediatrics Collaborate on Esophageal Atresia Treatment

Ipsen's Phase III BOLD Trial of Bylvay in Biliary Atresia Misses Primary Endpoint